References
- Surawicz C M, Elmer G W, Speelman P, McFarland L V, Chinn J, van Belle G. Prevention of antibiotic‐associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989; 96: 981–8
- Neu H C, Prince A, Neu C O, Garvey G J. Incidence of diarrhea and colitis associated with clindamycin therapy. J Infect Dis 1977; 135: s120–5
- Aronsson B, Mollby R, Nord C E. Occurrence of toxin‐producting Clostridium difficile in antibiotic‐associated diarrhea in Sweden. Med Microbiol Immunol 1981; 170: 27–35
- George W L, Rolfe R D, Finegold S M. Clostridium difficile and its cytotoxin in faeces of patients with antimicrobial agent associated diarrhea and miscellaneous conditions. J Clin Microbiol 1982; 15: 1049–53
- Clausen M R, Bonnén H, Tvede M, Mortensen P B. Colonic fermentation to short‐chain fatty acids is decreased in antibiotic‐associated diarrhea. Gastroenterology 1991; 101: 1497–504
- Høverstad T, Carlstedt‐Duke Lingaas E, Norin E, Saxerholt H, Steinbakk M, et al. Influence of oral intake of seven different antibiotics on fecal short‐chain fatty acid excretion in healthy subjects. Scand J Gastroenterol 1986; 21: 997–1003
- Heimdahl A, Nord C E. Effect of erytromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract. Eur J Clin Microbiol 1982; 1: 38–48
- McNeil I, Cummings J H, James W P T. Short chain fatty acid absorption by the human large intestine. Gut 1978; 19: 819–22
- Ruppin H, Bar‐Meir S, Soergel K H, Wood C M, Schmitt M G. Absorption of short chain fatty acids by the colon. Gastroenterology 1980; 78: 1500–7
- Roediger W E W, Moore A. Effect of short‐chain fatty acid on sodium absorption in isolated human colon perfused through the vascular bed. Dig Dis Sci 1981; 26: 100–6
- Roediger W E W. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980; 21: 793–8
- Roediger W E W. The colonic epithelium in ulcerative colitis: an energy‐deficiency disease?. Lancet 1980; 2: 712–5
- Rao S S C, Edwards C A, Austen C J, Bruce C, Read N W. Impaired colonic fermentation of carbohydrate after ampicillin. Gastroenterology 1988; 94: 928–32
- Mortensen P B, Clausen M R, Bonnén H, Hove H, Holtug K. Colonic fermentation of ispagula, wheat bran, glucose, and albumin to short chain fatty acids and ammonia evaluated in vitro in 50 subjects. JPEN 1992; 16: 433–9
- Gutmann I, Wahlefeld A W. Lactate determination with lactate dehydrogenase and NAD. Methods of enzymatic analysis, H U Bergmeyer. Academic Press, New York 1974; 1464–8
- Tvede M, Rask‐Madsen J. Bacteriotheraphy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1: 1156–60
- Englyst H N, Cummings J H. Non‐starch polysaccharides (dietary fiber) and resistant starch. Adv Exp Med Biol 1990; 270: 205–25
- Mortensen P B, Hove H, Clausen M R, Holtug K. Fermentation to short‐chain fatty acids and lactate in human faecal batch cultures. Scand J Gastroenterol 1991; 26: 1285–94
- Meijer‐Severs G J, van Santen E. Short chain fatty acids and organic acid concentrations in feces of 10 human volunteers and their correlation with anaerobe cultural counts over a 15‐month period. Scand J Gastroenterol 1989; 24: 1276–80
- Høverstad T, Fausa O, Bjørneklett A, Bøhmer T. Short‐chain fatty acids in the normal human feces. Scand J Gastroenterol 1984; 19: 375–81
- Hove H, Nordgaard‐Andersen I, Mortensen P B. Faecal DL‐lactate concentration in 100 gastrointestinal patients. Scand J Gastroenterol 1994; 29: 255–9
- Ramakrishna B S, Mathan V I. Colonic dysfunction in acute diarrhoea: the role of luminal short chain fatty acids. Gut 1993; 34: 1215–8
- Argenzio R A, Miller N, von Engelhardt W. Effect of volatile fatty acids on water and ion absorption from the goat colon. Am J Physiol 1975; 229: 997–1002
- Dubos R. The microbiota of the gastrointestinal tract. Gastroenterology 1966; 51: 868–74
- Lishman A H, Al‐Jumaili I J, Record C O. Spectrum of antibiotic‐associated diarrhoea. Gut 1981; 22: 34–7
- Viscidi R, Willey S, Bartlett J G. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patients populations. Gastroenterology 1981; 81: 5–9
- Wolfhagen M J H, Meijer K, Fluit A C, Torensma R, Bruinsma R A, Fleer A, et al. Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children. Gut 1994; 35: 1608–12